EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE |
212362 |
001 |
ANDA |
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE; ORAL |
5MG/1000MG |
No
|
No
|
2023/01/31
(TA)
|
--
|
MSN LABS PVT LTD |
None (Tentative Approval) |
EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE |
212362 |
002 |
ANDA |
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE; ORAL |
10MG/1000MG |
No
|
No
|
2023/01/31
(TA)
|
--
|
MSN LABS PVT LTD |
None (Tentative Approval) |
EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE |
212362 |
003 |
ANDA |
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE; ORAL |
12.5MG/1000MG |
No
|
No
|
2023/01/31
(TA)
|
--
|
MSN LABS PVT LTD |
None (Tentative Approval) |
EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE |
212362 |
004 |
ANDA |
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE |
TABLET, EXTENDED RELEASE; ORAL |
25MG/1000MG |
No
|
No
|
2023/01/31
(TA)
|
--
|
MSN LABS PVT LTD |
None (Tentative Approval) |